| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
|
Circulation
|
2011
|
2.01
|
|
2
|
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
|
Haematologica
|
2012
|
1.72
|
|
3
|
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
|
Blood
|
2011
|
1.64
|
|
4
|
Pulmonary hypertension in sickle cell disease.
|
Am J Cardiol
|
1994
|
1.44
|
|
5
|
Bayesian methods for multivariate modeling of pleiotropic SNP associations and genetic risk prediction.
|
Front Genet
|
2012
|
1.19
|
|
6
|
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
|
Blood
|
2012
|
1.12
|
|
7
|
Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
|
Am J Hematol
|
2012
|
1.10
|
|
8
|
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
|
PLoS One
|
2012
|
1.04
|
|
9
|
Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
|
JAMA
|
2008
|
1.02
|
|
10
|
Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.
|
PLoS One
|
2014
|
1.00
|
|
11
|
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
|
Circ Cardiovasc Genet
|
2014
|
0.95
|
|
12
|
Systemic fat embolism and pulmonary hypertension in sickle cell disease.
|
Hematol Oncol Clin North Am
|
1996
|
0.94
|
|
13
|
Pharmacotherapy in sickle cell disease--state of the art and future prospects.
|
Br J Haematol
|
2009
|
0.92
|
|
14
|
Genetic determinants of haemolysis in sickle cell anaemia.
|
Br J Haematol
|
2013
|
0.89
|
|
15
|
Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.
|
Hematology Am Soc Hematol Educ Program
|
2008
|
0.84
|
|
16
|
Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.
|
PLoS One
|
2014
|
0.81
|
|
17
|
Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease.
|
Transfusion
|
2016
|
0.77
|
|
18
|
Pulmonary hypertension and sickle hemoglobinopathy.
|
Chest
|
1990
|
0.75
|
|
19
|
The genetics of hemoglobin A2 regulation in sickle cell anemia.
|
Am J Hematol
|
2014
|
0.75
|
|
20
|
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
|
Clin J Am Soc Nephrol
|
2015
|
0.75
|